“Cases of Meige’s Syndrome Controlled Following Administration of Low-Dose Botulinum Toxin Type-A: A Serial Case Series” (2023) Magna Neurologica, 1(2), pp. 44–48. doi:10.20961/magnaneurologica.v1i2.700.